Leadership Transition at Carisma Therapeutics’ Board of Directors
Company Announcements

Leadership Transition at Carisma Therapeutics’ Board of Directors

Carisma Therapeutics ( (CARM) ) just unveiled an update.

Michael Torok is stepping down from Carisma Therapeutics’ board of directors due to other professional commitments, making way for the appointment of Sohanya Cheng. Cheng will join the audit committee and receive a compensation package including cash and stock options, aligning with the company’s non-employee director compensation policy. Her appointment reflects a seamless transition in leadership, offering stability and continuity for the company’s governance.

For detailed information about CARM stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyAlphabet upgraded, Boeing downgraded: Wall Street’s top analyst calls
TheFlyCarisma Therapeutics initiated with a Buy at EF Hutton
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App